BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anwar SL, Lehmann U. DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma. World J Gastroenterol 2014; 20(24): 7894-7913 [PMID: 24976726 DOI: 10.3748/wjg.v20.i24.7894] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 50] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Lv HC, Lv YY, Wang G, Zhang XH, Li SN, Yue XF, Lu W. Mechanism of miR-424-5p promoter methylation in promoting epithelial-mesenchymal transition of hepatocellular carcinoma cells. Kaohsiung J Med Sci 2022. [PMID: 35049148 DOI: 10.1002/kjm2.12499] [Reference Citation Analysis]
2 Chen Y, Yang S, Hu J, Yu C, He M, Cai Z. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma. PLoS One 2016;11:e0154939. [PMID: 27183310 DOI: 10.1371/journal.pone.0154939] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
3 Yuan R, Zhi Q, Zhao H, Han Y, Gao L, Wang B, Kou Z, Guo Z, He S, Xue X, Hu H. Upregulated expression of miR-106a by DNA hypomethylation plays an oncogenic role in hepatocellular carcinoma. Tumour Biol. 2015;36:3093-3100. [PMID: 25510666 DOI: 10.1007/s13277-014-2945-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
4 Pop S, Enciu AM, Tarcomnicu I, Gille E, Tanase C. Phytochemicals in cancer prevention: modulating epigenetic alterations of DNA methylation. Phytochem Rev 2019;18:1005-24. [DOI: 10.1007/s11101-019-09627-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
5 Mueller S, Dennison G, Liu S. An Assessment on Ethanol-Blended Gasoline/Diesel Fuels on Cancer Risk and Mortality. Int J Environ Res Public Health 2021;18:6930. [PMID: 34203568 DOI: 10.3390/ijerph18136930] [Reference Citation Analysis]
6 Rigalli JP, Ciriaci N, Arias A, Ceballos MP, Villanueva SS, Luquita MG, Mottino AD, Ghanem CI, Catania VA, Ruiz ML. Regulation of multidrug resistance proteins by genistein in a hepatocarcinoma cell line: impact on sorafenib cytotoxicity. PLoS One 2015;10:e0119502. [PMID: 25781341 DOI: 10.1371/journal.pone.0119502] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
7 Jingyue S, Xiao W, Juanmin Z, Wei L, Daoming L, Hong X. TFAP2E methylation promotes 5‑fluorouracil resistance via exosomal miR‑106a‑5p and miR‑421 in gastric cancer MGC‑803 cells. Mol Med Rep 2019;20:323-31. [PMID: 31115533 DOI: 10.3892/mmr.2019.10237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Vaca-Paniagua F, Oliver J, Nogueira da Costa A, Merle P, McKay J, Herceg Z, Holmila R. Targeted deep DNA methylation analysis of circulating cell-free DNA in plasma using massively parallel semiconductor sequencing. Epigenomics 2015;7:353-62. [PMID: 26077425 DOI: 10.2217/epi.14.94] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
9 Daher S, Massarwa M, Benson AA, Khoury T. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. J Clin Transl Hepatol. 2018;6:69-78. [PMID: 29607307 DOI: 10.14218/jcth.2017.00031] [Cited by in Crossref: 97] [Cited by in F6Publishing: 76] [Article Influence: 19.4] [Reference Citation Analysis]
10 Lei C, Jiao Y, He B, Wang G, Wang Q, Wang J. RIP140 down-regulation alleviates acute lung injury via the inhibition of LPS-induced PPARγ promoter methylation. Pulm Pharmacol Ther 2016;37:57-64. [PMID: 26921464 DOI: 10.1016/j.pupt.2016.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Nojima M, Matsui T, Tamori A, Kubo S, Shirabe K, Kimura K, Shimada M, Utsunomiya T, Kondo Y, Iio E. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma. Mol Cancer. 2016;15:31. [PMID: 27137948 DOI: 10.1186/s12943-016-0514-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
12 Cao MR, Han ZP, Liu JM, Li YG, Lv YB, Zhou JB, He JH. Bioinformatic analysis and prediction of the function and regulatory network of long non-coding RNAs in hepatocellular carcinoma. Oncol Lett 2018;15:7783-93. [PMID: 29740493 DOI: 10.3892/ol.2018.8271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sajadian SO, Ehnert S, Vakilian H, Koutsouraki E, Damm G, Seehofer D, Thasler W, Dooley S, Baharvand H, Sipos B, Nussler AK. Induction of active demethylation and 5hmC formation by 5-azacytidine is TET2 dependent and suggests new treatment strategies against hepatocellular carcinoma. Clin Epigenetics 2015;7:98. [PMID: 26366235 DOI: 10.1186/s13148-015-0133-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
14 Peng H, Du X, Zhang Y. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. Front Mol Biosci 2022;9:898567. [DOI: 10.3389/fmolb.2022.898567] [Reference Citation Analysis]
15 Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B, Lehmann U. hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma. World J Gastroenterol 2017; 23(9): 1568-1575 [PMID: 28321157 DOI: 10.3748/wjg.v23.i9.1568] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
16 V Subramaniam A, Yehya AHS, Cheng WK, Wang X, Oon CE. Epigenetics: The master control of endothelial cell fate in cancer. Life Sci 2019;232:116652. [PMID: 31302197 DOI: 10.1016/j.lfs.2019.116652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Ezzat WM, Amr KS, Elhosary YA, Hegazy AE, Fahim HH, Eltaweel NH, Kamel RR. Detection of DNA methylated microRNAs in hepatocellular carcinoma. Gene. 2019;702:153-157. [PMID: 30922710 DOI: 10.1016/j.gene.2019.02.080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tan HW, Leung CO, Chan KK, Ho DW, Leung MS, Wong CM, Ng IO, Lo RC. Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma. Int J Cancer 2019;145:1860-73. [PMID: 30834518 DOI: 10.1002/ijc.32248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
19 Yeh MM, Yeung RS, Apisarnthanarax S, Bhattacharya R, Cuevas C, Harris WP, Hon TLK, Padia SA, Park JO, Riggle KM, Daoud SS. Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience. World J Hepatol 2015; 7(11): 1460-1483 [PMID: 26085907 DOI: 10.4254/wjh.v7.i11.1460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
20 Tanaka A, Watanabe S. Can cytoplasmic donation rescue aged oocytes? Reprod Med Biol 2019;18:128-39. [PMID: 30996676 DOI: 10.1002/rmb2.12252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Jiang Y, Chen J, Tong J, Chen T. Trichloroethylene-induced gene expression and DNA methylation changes in B6C3F1 mouse liver. PLoS One. 2014;9:e116179. [PMID: 25549359 DOI: 10.1371/-journal.pone.0116179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Anwar SL, Lehmann U. MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas. J Clin Med. 2015;4:1631-1650. [PMID: 26295264 DOI: 10.3390/jcm4081631] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
23 Murray B, Barbier-Torres L, Fan W, Mato JM, Lu SC. Methionine adenosyltransferases in liver cancer. World J Gastroenterol 2019; 25(31): 4300-4319 [PMID: 31496615 DOI: 10.3748/wjg.v25.i31.4300] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
24 Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3960-3969 [PMID: 25852282 DOI: 10.3748/wjg.v21.i13.3960] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
25 Jiang Y, Dai Y, Chen T. Advances in TCE Toxicology. Elsevier; 2017. pp. 51-79. [DOI: 10.1016/b978-0-12-812522-9.00002-6] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
26 Dioufa N, Clark AM, Ma B, Beckwitt CH, Wells A. Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells. Mol Cancer 2017;16:172. [PMID: 29137633 DOI: 10.1186/s12943-017-0740-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
27 Hayes CN, Chayama K. MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int J Mol Sci. 2016;17:280. [PMID: 26927063 DOI: 10.3390/ijms17030280] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 18.7] [Reference Citation Analysis]
28 Ge ZJ, Schatten H, Zhang CL, Sun QY. Oocyte ageing and epigenetics. Reproduction 2015;149:R103-14. [PMID: 25391845 DOI: 10.1530/REP-14-0242] [Cited by in Crossref: 83] [Cited by in F6Publishing: 46] [Article Influence: 10.4] [Reference Citation Analysis]
29 Huang W, Li T, Yang W, Chai X, Chen K, Wei L, Duan S, Li B, Qin Y. Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis. Genet Test Mol Biomarkers 2015;19:295-302. [PMID: 25923138 DOI: 10.1089/gtmb.2014.0292] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
30 Xie Y, Zong P, Wang W, Liu D, Li B, Wang Y, Hu J, Ren Y, Qi Y, Cui X, Chen Y, Liu C, Li F. Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas. Exp Mol Pathol 2015;98:446-54. [PMID: 25773680 DOI: 10.1016/j.yexmp.2015.03.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
31 Sui X, Zhu J, Zhou J, Wang X, Li D, Han W, Fang Y, Pan H. Epigenetic modifications as regulatory elements of autophagy in cancer. Cancer Letters 2015;360:106-13. [DOI: 10.1016/j.canlet.2015.02.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
32 Ramos-lopez O, Riezu-boj JI, Milagro FI, Alfredo Martinez J; On Behalf of the MENA Project. Association of Methylation Signatures at Hepatocellular Carcinoma Pathway Genes with Adiposity and Insulin Resistance Phenotypes. Nutrition and Cancer 2019;71:840-51. [DOI: 10.1080/01635581.2018.1531136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Chen X, Luo J, Liu J, Chen T, Sun J, Zhang Y, Xi Q. Exploration of the Effect on Genome-Wide DNA Methylation by miR-143 Knock-Out in Mice Liver. Int J Mol Sci 2021;22:13075. [PMID: 34884879 DOI: 10.3390/ijms222313075] [Reference Citation Analysis]
34 Aydin C, Kalkan R. Cancer Treatment: An Epigenetic View. Glob Med Genet 2020;7:3-7. [PMID: 32879917 DOI: 10.1055/s-0040-1713610] [Reference Citation Analysis]
35 Huang Y, Wei L, Zhao RC, Liang WB, Zhang J, Ding XQ, Li ZL, Sun CJ, Li B, Liu QY, He JY, Yu XQ, Gao B, Chen MM, Sun AM, Qin Y. Predicting hepatocellular carcinoma development for cirrhosis patients via methylation detection of heparocarcinogenesis-related genes. J Cancer 2018;9:2203-10. [PMID: 29937940 DOI: 10.7150/jca.24024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhao NH, Qian Y, Wu CS, Wang JW, Fang Y, Fan XP, Gao S, Fan YC, Wang K. Diagnostic value of NKG2D promoter methylation in hepatitis B virus-associated hepatocellular carcinoma. Biomark Med 2019;13:1093-105. [PMID: 31411040 DOI: 10.2217/bmm-2019-0102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Wahid B, Ali A, Rafique S, Idrees M. New Insights into the Epigenetics of Hepatocellular Carcinoma. Biomed Res Int 2017;2017:1609575. [PMID: 28401148 DOI: 10.1155/2017/1609575] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
38 Machado ART, Aissa AF, Ribeiro DL, Ferreira RS Jr, Sampaio SV, Antunes LMG. BjussuLAAO-II induces cytotoxicity and alters DNA methylation of cell-cycle genes in monocultured/co-cultured HepG2 cells. J Venom Anim Toxins Incl Trop Dis 2019;25:e147618. [PMID: 31131003 DOI: 10.1590/1678-9199-JVATITD-1476-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Ouyang X, Wang Z, Yao L, Zhang G. Elevated CELSR3 expression is associated with hepatocarcinogenesis and poor prognosis. Oncol Lett 2020;20:1083-92. [PMID: 32724347 DOI: 10.3892/ol.2020.11671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Jiang Y, Chen J, Tong J, Chen T. Trichloroethylene-induced gene expression and DNA methylation changes in B6C3F1 mouse liver. PLoS One 2014;9:e116179. [PMID: 25549359 DOI: 10.1371/journal.pone.0116179] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
41 Liu D, Liu P, Cao L, Zhang Q, Chen Y. Screening the key genes of hepatocellular adenoma via microarray analysis of DNA expression and methylation profiles. Oncol Lett. 2017;14:3975-3980. [PMID: 28943905 DOI: 10.3892/ol.2017.6673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
42 Abo El-Khair SM, Elalfy H, Diasty M, Ebrahim EE, Elsamanoudy AZ. Methylation degree of metalloproteinase inhibitor RECK gene: Links to RECK protein level and hepatocellular carcinoma in chronic HCV infection patients. J Biochem Mol Toxicol 2021;:e22886. [PMID: 34392581 DOI: 10.1002/jbt.22886] [Reference Citation Analysis]
43 Zhang Y, Zhao Y, Sun S, Liu Z, Zhang Y, Jiao S. Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients. Tumour Biol 2016;37:10155-60. [PMID: 26831656 DOI: 10.1007/s13277-015-4662-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
44 Shouval D, Friedman SL. Focusing on the past, present, and future of hepatology. J Hepatol. 2014;61:1196-1198. [PMID: 25195549 DOI: 10.1016/j.jhep.2014.08.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Gu Y, Wang X, Liu H, Li G, Yu W, Ma Q. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1. Oncol Rep 2018;40:1863-74. [PMID: 30106440 DOI: 10.3892/or.2018.6621] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
46 Sidhu K, Kapoor NR, Pandey V, Kumar V. The “Macro” World of microRNAs in Hepatocellular Carcinoma. Front Oncol. 2015;5:68. [PMID: 25859429 DOI: 10.3389/fonc.2015.00068] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
47 Day CR, Kempson SA. Betaine chemistry, roles, and potential use in liver disease. Biochim Biophys Acta. 2016;1860:1098-1106. [PMID: 26850693 DOI: 10.1016/j.bbagen.2016.02.001] [Cited by in Crossref: 91] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
48 Colaprico A, Cava C, Bertoli G, Bontempi G, Castiglioni I. Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer. Biomed Res Int 2015;2015:831314. [PMID: 26240829 DOI: 10.1155/2015/831314] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
49 Mostafa WSEM, Al-Dahr MHS, Omran DAH, Abdullah ZF, Elmasry SH, Ibrahim MN. Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients. Clin Mol Hepatol 2020;26:60-9. [PMID: 31630500 DOI: 10.3350/cmh.2019.0051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Li CW, Chang PY, Chen BS. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method. Oncotarget 2016;7:79453-73. [PMID: 27821810 DOI: 10.18632/oncotarget.13100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
51 Gao F, Xia Y, Wang J, Lin Z, Ou Y, Liu X, Liu W, Zhou B, Luo H, Zhou B, Wen B, Zhang X, Huang J. Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma. Genome Biol 2014;15:533. [PMID: 25517360 DOI: 10.1186/s13059-014-0533-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
52 Varghese RS, Barefoot ME, Jain S, Chen Y, Zhang Y, Alley A, Kroemer AH, Tadesse MG, Kumar D, Sherif ZA, Ressom HW. Integrative Analysis of DNA Methylation and microRNA Expression Reveals Mechanisms of Racial Heterogeneity in Hepatocellular Carcinoma. Front Genet 2021;12:708326. [PMID: 34557219 DOI: 10.3389/fgene.2021.708326] [Reference Citation Analysis]
53 Anwar SL, Hasemeier B, Schipper E, Vogel A, Kreipe H, Lehmann U. LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype. PLoS One 2019;14:e0216374. [PMID: 31059558 DOI: 10.1371/journal.pone.0216374] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]